Utilization ofglutathione S-transferase Mu 1- andTheta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies
- 18 March 2013
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 9 (6), 725-736
- https://doi.org/10.1517/17425255.2013.780027
Abstract
Glutathione S-transferases (GSTs) are Phase II drug-metabolizing enzymes that catalyze the conjugation of electrophilic compounds to glutathione. This reaction generally detoxifies reactive metabolites of xenobiotics, such as drugs and environmental chemicals, and therefore, GSTs are considered toxicologically important enzymes. Human GST genes display genetic polymorphisms, and the impact of null genotypes of GST Mu 1 (GSTM1) and GST Theta 1 (GSTT1) have been extensively studied. Recently, corresponding Gstm1- and Gstt1-null mice have been developed. This review covers GSTM1- and GSTT1-null genotypes in humans and utilization of Gstm1- and Gstt1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity (ADMET) studies. Furthermore, the possibility of Gstm1- and Gstt1-null mice as models of humans with GSTM1- and GSTT1-null genotypes is discussed. The experimental approach to assess the impact of GSTM1- and GSTT1- null genotypes on ADMET is very limited so far. Gstm1- and Gstt1-null mice have potential as human models, since null genotypes of GSTM1/Gstm1 and GSTT1/Gstt1 decreased hepatic GST activities toward p-nitrobenzyl chloride and dichloromethane, respectively, in both humans and mice. This suggests functional similarity of GSTM1 and GSTT1 toward some substrates between humans and mice.Keywords
This publication has 79 references indexed in Scilit:
- PHASE II DRUG METABOLIZING ENZYMESBiomedical Papers, 2010
- A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent GlucuronidationDrug Metabolism and Disposition, 2010
- Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and ClinicalThe AAPS Journal, 2008
- Structure, Function and Polymorphism of Human Cytosolic SulfotransferasesCurrent Drug Metabolism, 2008
- The use of glutathione transferase-knockout mice as pharmacological and toxicological modelsExpert Opinion on Drug Metabolism & Toxicology, 2007
- GLUTATHIONE TRANSFERASESAnnual Review of Pharmacology and Toxicology, 2005
- Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase—deficient miceNature Medicine, 2005
- DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOSDrug Metabolism and Disposition, 2004
- High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolismJournal of Pharmaceutical Sciences, 2004
- Targeted Disruption of the Mouse Estrogen Sulfotransferase Gene Reveals a Role of Estrogen Metabolism in Intracrine and Paracrine Estrogen RegulationEndocrinology, 2001